CTD M 6.25/25

CTD-M 6.25/25 Tablet ER is utilized for the management of hypertension, which is characterized by elevated blood pressure levels. This medication is particularly beneficial when a single treatment fails to adequately control blood pressure. In addition to regulating blood pressure, it also plays a role in minimizing the risk of future cardiovascular events, such as heart attacks and strokes. Initiating treatment with this medication promptly can significantly enhance survival rates in individuals experiencing heart attacks. The tablet can be administered with or without food, although it is advised to take it in the morning to mitigate the need for nighttime urination. It is important to continue taking this medication for the duration prescribed by your healthcare provider. Discontinuing use without medical guidance is inadvisable, as hypertension often presents with no noticeable symptoms, and stopping the medication may lead to a deterioration of your condition. Engaging in regular physical activity, maintaining a healthy weight, and adhering to a balanced diet can further aid in controlling blood pressure levels. It is crucial to follow your healthcare provider’s recommendations throughout the course of treatment. Some patients may experience mild adverse effects such as nausea, constipation, diarrhea, or fatigue. Should any of these symptoms become bothersome, escalate in severity, or persist, it is essential to contact your healthcare professional. Ensuring adequate hydration while on this medication can help alleviate issues such as muscle weakness and dry mouth. Low blood pressure may result in dizziness or headaches, though these symptoms typically improve over time. Before starting this medication, inform your doctor of any existing kidney or liver issues, and if you are pregnant or breastfeeding, seek your doctor’s advice. Regular monitoring of blood pressure, kidney function, blood glucose levels, and essential electrolytes is important to confirm the medication’s efficacy and safety.